SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-019442
Filing Date
2020-07-16
Accepted
2020-07-16 20:19:48
Documents
1
Period of Report
2020-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4301
  Complete submission text file 0000899243-20-019442.txt   5982
Mailing Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472 617-393-5925
Pandion Therapeutics, Inc. (Issuer) CIK: 0001807901 (see all company filings)

IRS No.: 833015614 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 VESEY ST 28TH FL NEW YORK NY 02118
Business Address 200 VESEY ST 28TH FL NEW YORK NY 02118 646 873-4311
JDRF T1D Fund LLC (Reporting) CIK: 0001817634 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0630
Type: 3 | Act: 34 | File No.: 001-39381 | Film No.: 201032542